JPMorgan analyst C. Stephen Tusa Jr. reiterated an Overweight rating on Emerson (NYSE: EMR).The analyst comments "We expect 1Q EPS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE